Lavinia Life Sciences Private Limited, a active private limited company, was established on 30 November 2018 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999MH2018PTC317722. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
Its leadership includes Shyam Purushothaman Nair (Director), Neelam Sandeep Mhatre (Director), Sandip Pramod Mhatre (Director). Past directors included Neelam Sandeep Mhatre, Sandip Pramod Mhatre. It holds ₹9.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B - 106, Techno City, X 4/1 Ttc Area, Midc, Mahape,, Navi Mumbai, Maharashtra, 400705.
U74999MH2018PTC317722
317722
30 November 2018
₹1.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Lavinia Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shyam Purushothaman Nair | Director | 30 Nov 2018 | Current |
| Neelam Sandeep Mhatre | Director | 03 Jan 2020 | Current |
| Sandip Pramod Mhatre | Director | 03 Jan 2020 | Current |
| Vijaykumar Vazakttuvaliya Raghavan Nair | Director | 30 Nov 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lavinia Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 4310.62% increase. The company also saw a substantial fall in profitability, with a 608.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 87.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Lavinia Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹97,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2020 | Others | ₹4.50 Cr | Open |
| 24 Dec 2020 | Others | ₹5.25 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lavinia Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lavinia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lavinia Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Lavinia Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Lavinia Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 4.50 Cr with Charge ID 100406518 was registered on 24 Dec 2020. was completed.
The activity A charge with Others amounted to Rs. 5.25 Cr with Charge ID 100405879 was registered on 24 Dec 2020. was completed.
The activity Neelam Sandeep Mhatre was appointed as a Director was appointed as a Director on 03 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
Sandip Pramod Mhatre was appointed as a Director was appointed as a Director on 03 Jan 2020 & has been associated with this company since 5 years 10 months . was recorded as a recent event.
The CIN of Lavinia Life Sciences Private Limited is U74999MH2018PTC317722.
Lavinia Life Sciences Private Limited is headquartered at B - 106, Techno City, X 4/1 Ttc Area, Midc, Mahape,, Navi Mumbai, Maharashtra, 400705.
Lavinia Life Sciences Private Limited was incorporated on 30 November 2018.
The current directors of Lavinia Life Sciences Private Limited are
The primary industry of Lavinia Life Sciences Private Limited is Manufacturing.
Lavinia Life Sciences Private Limited is unlisted.
The authorized capital of Lavinia Life Sciences Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX